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Abstract 
Lumican belongs to the small leucine-rich
repeat proteoglycan (SLRP) gene family and
has been reported to exist in the cornea, inter-
vertebral  disc  and  tendon.  Lumican  plays  a
significant role in the assembly and regula-
tion of collagen fibres. The human temporo-
mandibular  joint  (TMJ)  disc  is  made  up  of
fibrocartilage  with  an  extracellular  matrix
(ECM)  composed  of  collagen  and  proteogly-
cans. The existence and behaviour of lumican
have not been studied in the human TMJ disc.
Therefore,  we  used  immunohistochemical
methods to detect lumican, CD34 and vascular
endothelial growth factor (VEGF) and histo-
chemical  staining  with  toluidine  blue  in  13
human TMJ specimens (10 surgically removed
and 3 obtained from autopsy). In both normal
and deformed discs we observed staining with
toluidine  blue.  We  found  that  the  area  of
metachromasia inside the deformed disc was
uneven and expression of lumican was strong
in  the  areas  negative  for  metachromasia.
Staining  of  VEGF  and  CD34  inside  the
deformed  disc  was  seen.  We  confirmed  the
expression of lumican in the human TMJ disc
and showed that a large number of fibroblast-
like cells existed in the area of strong lumican
expression.  These  new  findings  about  the
behaviour of lumican suggest that it may play
a key role in the generation of a new collagen
network by fibroblast-like cells.
Introduction
In 1988, Scott
1 reported that proteokeratan
sulfates (PKSs) were associated with collagen
fibrils  at  specific  binding  sites.  In  1991,
Funderburgh  et  al.
2 and  Blochberger  et  al.
3
reported the existence of lumican in connec-
tive tissues. Lumican belongs to the family of
SLRPs that plays a role in the ECM. The SLRP
gene family has expanded in the past decade to
encompass 17 genes. Recently, the gene fami-
ly has been subdivided into 5 classes on sever-
al  parameters  basis,  including  conservation
and homology at the protein and genomic lev-
els, the presence of characteristic N-terminal
Cys-rich  clusters  with  defined  spacing  and
chromosomal organization.
4-7 Lumican is clas-
sified  as  class  2  in  the  SLRP gene  family.
Lumican has been shown to exist in the con-
nective tissue of many organs, including the
cornea, intervertebral disc and tendon, and its
behaviour has been studied in several clinical
fields.
8-12 Scott
13 have indicated that PKSs play a
role in orienting and organizing the collagen
fibrils, thus helping to establish and maintain
tissue  shape.  Kafienah  et  al.
14 reported  that
lumican plays a role in limiting the growth of
type II collagen fibrils during cartilage tissue
engineering. Funderburgh et al.
15 revealed that
lumican  is  deeply  involved  in  collagen  fibre
repair  and  adjustment,  and  Saika  et  al.
16
showed  that  lumican  expressed  in  injured
epithelium may modulate cell behaviours such
as adhesion or migration, thus contributing to
corneal epithelial wound healing. In addition,
Chakravarti et al.
17 revealed the early regula-
tion of collagen structure by lumican during
postnatal development of the cornea.
Extracellular matrix is composed mainly of
collagen and proteoglycan in the articular disc
of the TMJ.
18,19 The articular disc lies between
the condylar head and the glenoid fossa and
helps to absorb force during opening and clos-
ing  movements  and  occlusion.  Chemical
stress  due  to  cytokines  and  physical  stress
due to malocclusion have been considered to
be major causes of internal derangement (ID)
and  osteoarthritis  (OA)  in  disorders  of  the
TMJ. It is still unclear what kind of changes
happens in the TMJ disc affected by ID and
OA and no studies have examined the expres-
sion of lumican in the human TMJ disc with
ID or OA. 
Based on the above, we hypothesised that
lumican expression was likely to be increased
in the deformed discs. Therefore, this study
used histology and immunohistochemistry to
compare human TMJ discs from normal and
diseased individuals.
Materials and Methods
Thirteen human TMJ discs (10 diseased and
3 normal controls) were used in this study. The
10 diseased human TMJ specimens were sur-
gically removed from 10 patients (8 female and
2 male) because of ID with severe pain and
dysfunction.  All  the  patients  provided  their
informed consent, and this study was approved
by the Ethics Committee of Wakayama Medical
University.
The  patients’  age  ranged  from  20  to  72
years, with a mean age of 43.8 years (Table 1).
Magnetic resonance imaging revealed that all
patients had anterior disc displacement with-
out  reduction.  Most  of  the  patients  experi-
enced severe pain and all patients experienced
disturbances  of  function  without  reduction.
The patients did not have a history of trauma
to the TMJ, and none of them had ankylosis.
The three normal TMJ disc specimens were
obtained  by  autopsy  from  3  separate  female
patients (average age 56.7 years) who did not
have  a  clinical  history  of  TMJ  disturbances
(fresh  cadavers);  they  died  of  diseases  not
related to TMJ (a tongue cancer, a gastric can-
cer and a breast cancer). At the time of autop-
sy, it was confirmed that the patients did not
suffer  from  anterior  disc  displacement  or
deformation.  Microscopic  examination  of
haematoxylin-eosin-stained  sections  did  not
reveal any pathological changes. All specimens
were  cut  sagittally  and  immediately  fixed
overnight in phosphate buffered saline (PBS)
solution  containing  4%  paraformaldehyde,
embedded in paraffin wax, and cut into 5 mm-
thick sections. 
Immunohistochemical methods
For immunohistochemical staining, the sec-
tions were dewaxed in xylene and rehydrated
through an alcohol series. Endogenous peroxi-
dase was blocked by immersing the sections in
0.3% H2O2 in methanol for 20 min at room tem-
perature. The specimens were blocked with 3%
skimmed milk (in 0.01% Tween-PBS) for 60
min  at  room  temperature  and  were  then
stained using a rabbit polyclonal primary anti-
body  against  lumican  (Wakayama  Medical
University, Wakayama, Japan) at 4°C for 24 h.
The anti-lumican polyclonal antibody was used
at a dilution of 1: 800. After washing with PBS,
the specimens were treated with the secondary
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antibody using the EnVision™ + System-HRP
Labelled  Polymer,  Anti-Rabbit  (catalogue  no.
K4003, Dako Corporation, Tokyo, Japan) for 60
min at room temperature. Colour was devel-
oped  using  the  Liquid  DAB+  Substrate
Chromogen  System  (catalogue  no.  K3468,
Dako Corporation, Tokyo, Japan) followed by
counterstaining  with  Mayer’s  haematoxylin
(No.3000-2 Muto Pure Chemicals Corporation,
Tokyo,  Japan).  For  immunohistochemical
staining  of  CD34  and  vascular  endothelial
growth factor (VEGF), anti-human CD34 mon-
oclonal antibody (Nichirei, Tokyo, Japan) and
anti- human VEGF polyclonal antibody (Takara,
Shiga, Japan) were used at a dilution of 1:5
and  1:3000,  respectively.  Negative  controls
were subjected to the same protocol but with-
out the primary antibody. 
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Figure 1. (A, B, C, D) Lumican expression and toluidine blue staining in the human TMJ disc (scale bar = 100 mm). (A) Lumican expres-
sion in the normal disc. (B) Metachromasia in the normal disc. (C) Strong lumican expression in the deformed disc (asterics: uneven or
weak expression). (D) Metachromasia in the deformed disc (asterics: positive areas). All specimens are sagittal sections.
[European Journal of Histochemistry 2010; 54:e34]
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Table 1. Characteristics of patients with temporomandibular disorders included in this study. 
Sample no. Sex Age Diagnosis Symptom Displaement 
(pain) (dysfunction) of TMJ disc
1 Female 24 ID and OA ++ +
2  Female 52 ID and OA ++ +
3 Female 20 ID and OA ++ +
4  Male 72 ID and OA –+ +
5 Female 52 ID and OA –+ +
6 Male 64 ID and OA –+ +
7 Female 34 ID and OA –+ +
8 Female 32 ID and OA ++ +
9 Female 29 ID and OA ++ +
10 Female 59 ID and OA ++ +
11 Female 61 Autopsy sample –– –
12 Female 61 Autopsy sample –– –
13 Female 48 Autopsy sample –– –[page 150] [European Journal of Histochemistry 2010; 54:e34]
Histological methods
Histological staining was performed using
toluidine  blue.  Sections  were  dewaxed  in
xylene  and  rehydrated  through  an  alcohol
series. After washing with distilled water, sec-
tions were stained with 0.05% (w/v) toluidine
blue (pH 7.0) for 1 min. 
Results
Our findings in the human TMJ discs were
as follows. To detect the localization of lumican
in the whole human TMJ disc, immunohisto-
chemical analysis was performed. The expres-
sion of lumican was detectable in both normal
and deformed discs. In normal discs, positive
staining of lumican was observed in the con-
nective tissue around the disc and the disc sur-
face, and weak staining for lumican observed
inside the disc; whereas in deformed disc the
strong expression also spread to the inside of
the disc (Figure 1A, C). In both normal and
deformed discs, metachromasia was detected
by toluidine blue staining (Figure 1B, D).
In  all  discs  we  identified  fibroblast-like
cells, fibrochondrocytes, without a pericellular
halo; and chondrocyte-like cells with rounded
nuclei  surrounded  by  a  large  halo  of  cyto-
plasm.  In  normal  discs,  the  expression  of
lumican was weak surrounding all the cells
(Figure 2A). In deformed discs, lumican was
expressed in areas with many fibroblast-like
cells  (Figure  2B).  On  the  other  hand,  the
expression of lumican was weak surrounding
fibrochondrocytes  and  chondrocyte-like  cells
(Figure 2C, D).
We  analyzed  the  discs  following  staining
with  anti-human  CD34  monoclonal  antibody
and  anti-human  VEGF  polyclonal  antibody.
Positive staining of VEGF and CD34 within the
deformed discs was observed (Figure 3A, C),
which  was  not  only  found  in  normal  discs
(Figure 3B, D). 
Discussion
Several recent studies have cast light on the
localisation  and  function  of  lumican.
8-12 Fibril-
associated molecules such as lumican have been
implicated in regulating the progression of fibril
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Figure 2. (A, B, C, D) Immunohistochemical staining of lumican in the TMJ discs (scale bar = 25 mm). (A) The fibroblast-like cells (arrow-
head) and the fibrochondrocyte (black arrow), the chondrocyte-like cell (white arrow) in the normal disc (enlargement of circle in Figure 1A).
(B) Fibroblast-like cells (arrows) (enlargement of circle in Figure 1C); (C) Fibrochondrocytes (arrows) (enlargement of circle in Figure 1C);
(D) Chondrocyte-like cells (arrow) in the deformed disc (enlargement of rectangle in Figure 1C). All specimens are sagital sections.
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assembly through a series of steps leading to
structurally  and  mechanically  mature  fibrils.
20
Electron microscopic investigations of lumican-
null mice reveal deregulated growth of collagen
fibrils with a significant proportion of abnormal-
ly thick fibrils in skin and cornea.
10 Changing
patterns of abundance of lumican observed with
age  suggest  that  the  disc  may  have  different
requirements for the composition of its extracel-
lular matrix at different stages of life.
9 Although
lumican has been studied in the cornea, tendon
and  intervertebral  disc,  very  little  has  been
reported on lumican in the TMJ disc. 
In this study, we focused on the following
points; comparison of the positive reactions of
toluidine  blue,  CD34  and  VEGF  in  the
deformed  discs,  confirmation  of  lumican
expression within the TMJ disc and its rela-
tionship to disc cells.
Firstly,  the  most  interesting  finding  was
identified  by  toluidine  blue  staining.
Metachromasia could be seen in most areas
of both normal and deformed discs. However,
areas  showing  strong  metachromasia  coin-
cided with weak expression of lumican in all
the discs. We found that the positive area of
metachromasia in the inside of the deformed
disc was uneven and expression of lumican
was strong in the areas negative for meta-
chromasia.
Toluidine blue binds to hyaluronic acid and
glycosaminoglycans (GAGs). The large proteo-
glycans  of  the  TMJ  disc  are  aggrecan,
21-23
which  consist  of  a  core  protein  covalently
linked to more than 100 chondroitin sulphate
side chains.
24
In corneal lumican, it has been reported that
three of five binding sites are acceptors for
keratan  sulphate.
2,25,26 Thus,  we  inferred  that
GAGs-rich ECM decreases due to the deforma-
tion  of  TMJ  discs,  while  GAGs-poor  lumican
increases with the change of ECM, so that dif-
ferences in the areas positive for lumican and
metachromasia may appear.
Secondly, we identified positive expression
of CD34 and VEGF in the deformed discs and
found  that  lumican  positive  areas  could  be
observed  not  only  on  the  surface  but  also
spread to the inside of the disc. VEGF belongs
to the platelet derived growth factor family.
27
Angiogenesis is accompanied by the expres-
sion  of  angiogenic  mitogen  such  as  VEGF,
which involves the formation of new blood ves-
sels from pre-existing vessels to form a capil-
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Figure 3. (A, B, C, D) Immunohistochemical staining of CD34 and VEGF in the TMJ discs (scale bar = 50 mm). (A) Weak CD34 is
observed sporadically within the normal disc. (B) Strong CD34 expression is observed in the wall of newly formed capillaries while weak
expression is seen in the extracellular matrix. (C) VEGF expression was not found in the normal disc. (D) Strong VEGF expression is
seen in the wall of newly formed capillaries. All specimens are sagital sections.
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lary networks.
28,29 CD34 is another transmem-
brane  glycoprotein  present  on  endothelial
cells,  leukemic  cells,  and  some  progenitor
cells,  which  is  produced  by  endothelial  cells
and associated with angiogenesis.
30,31 Yoshida
et al.
31 reported that the presence of CD34 cor-
relates  with  the  process  of  angiogenesis
induced by internal derangement of the TMJ
and that new growth of blood capillaries is dis-
tributed in the internal derangement of human
TMJ discs.
31,32
Leonardi et al. reported that in normal discs,
fibroblast-like  cells,  fibrochondrocytes  and
chondrocyte-like cells are either unstained or
only weakly immunostained by VEGF antibody,
while  in  disc  specimens  from  internal
derangement of the TMJ with significant tis-
sue degeneration/regeneration, VEGF is con-
sistently expressed.
33Thus, we suggest that the
spreading expression of lumican to the inside
of the disc might be affected by inflammatory
cytokines from blood capillaries. 
The human TMJ disc has been said to con-
tain fibroblast-like cells, fibrochondrocytes and
chondrocyte-like cells.
34 We confirmed that the
large number of fibroblast-like cells co-localise
with lumican expression in our specimens. In
contrast,  little  lumican  expression  was
observed in the vicinity of fibrochondrocytes
and chondrocyte-like cells. In the current study
lumican  up-regulates  before  epithelial-mes-
enchymal transition (EMT) of the lens epithe-
lial cells, which is characterized by a fibroblast-
like  morphology  and  by  expression  of  a-
smooth  muscle  actin  (aSMA)  and  collagen
type I.
35,36It has been suggested that the up-reg-
ulation of aSMA immunolabelling is associat-
ed with histopathological findings and in par-
ticular with an attempt for disc healing and
plays an important role in the favourable evo-
lution of a pathological phenomenon, such as
in  the  case  of  deformed  disc.
37 Vij  et  al.
revealed that Lumcan (-/-) mouse embryonic
fibroblasts (MEF), compared to their wild type
counterparts, display increased rates of prolif-
eration and decreased apoptosis, and lumican
appears to regulate these cellular functions by
modulating specific cell growth and apoptosis
mediators.
38 For the reasons mentioned above,
we suggested that expression of lumican may
relate to an increase and a decrease of fibrob-
last-like cell in the TMJ disc and fibrosis of the
deformed disc.
In summary, lumican expression may play a
key role in the generation of a new collagen
network by fibroblast-like cells. On the basis of
these results, further research should be con-
ducted  to  understand  the  involvement  of
mechanical stress acting on disc cells and pro-
teoglycans in the TMJ disc and would be neces-
sary to investigate a role for lumican in the
regulation  of  collagen  assembly  using  lumi-
can-null mice.
36,39
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